.jpg)
BJOG Editors’ Disclosures of Interests
Hesham Al-Inany
Hesham Al-Inany received an Honororia for speaking in two symposium sponsored by IBSA in 2003 and 2004. His PhD thesis was partly covered by IBSA and Ferring.
Adam Balen
Consultant to Ferring. Advisory Board and honorarium received from Organon, Serono, Shire and Schering. Funding includes Ferring, Serono and Organon. NIAC, Verity, PCOS UK. RCOG involvement: RCOG Committee member and Study Group
Mike Belfort
During the last three years Mike Belfort has received funding and honoraria to support speaking at various scientific and educational meetings sponsored by Symposia Medicus, Columbia University, Yale University, The University of California San Francisco, Boston University, The Medical Intelligence Corporation, The Karolinska University, Hospital Corporation of America, The American College of Obstetricians and Gynecologists, and the Colombian Perinatal Association.
He has received funding to attend Board meetings of the Society for Maternal Fetal Medicine. He has been treated to dinners while discussing fetal monitoring technology from representatives of Neoventa. He has received fees for medicolegal opinions from various solicitors.
Vincenzo Berghella
Vincenzo Berghella ended his period on the speaker's bureau for Adeza in 2006. He will receive royalties from Informa Healthcare for the books 'Obstetric Evidence Based Guidelines' and 'Maternal-Fetal Evidence Based Guidelines', published in 2007. Cytyc sponsored a chapter signing for these books in 2007. He attended a meeting on progesterone for prevention of preterm birth sponsored by Columbia Laboratories in 2007.
Amar Bhide
In the last three years Amar Bhide has received grant funding from St. George’s Hospital charitable trust towards conducting research. He has received funding to defray the expenses of attendance at meetings from Deenanath Mangeshkar Hospital and Terna Medical college in India, Royal Jubilee Maternity Hospital, Belfast, the Society of Obstetricians and Gynaecologists of the Netherlands and Ain Shams University, Egypt. He has been treated to dinner while attending a meeting with representatives of GE Healthcare. He has received honorarium for examining at MRCOG courses held at Queen Elizabeth II Hospital and St. George’s Hospital. He has received authors’ royalty of the three books that he has authored.
Patrick Chien
During the last three years Patrick Chien has received funding from Ferring Pharmaceutical and Hologic UK (formerly Cytyc UK) to attend meetings sponsored by these companies.
Non-financial disclosures:
- Co-opted member of Scottish Committee of RCOG (SCRCOG)
- Director of Scottish Hydatiform Mole Follow-up service
- Examiner of Part II MRCOG
- SCRCOG deputy representative on Scottish Intercollegiate Guideline Network Council (SIGN)
- Member of guideline development group for updating SIGN Guideline 60: Postnatal Depression and Puerperal Psychosis
Donald Dudley
Donald Dudley has no ‘disclosure of interests’ to report.
Ellis Downes
Ellis Downes consults for Conceptus and Covidien. He has received hospitality from Hologic and Microsulis. Microsulis have also sponsored expenses to attend overseas conferences. He has received fees for medico-legal opinion from instructing solicitors.
Tarek El-Toukhy invited in 2007 to attend ESHRE conference in Lyon by a Serono pharmaceuticals.
Vanessa Harry
Vanessa has received funding from NHS Research and Development Department at Aberdeen Royal Infirmary to cover the cost of research/functional MRI examinations.
Paul Hilton
Within the last 10 years, Paul Hilton has been: principal investigator in a trial of surgery for stress urinary incontinence funded by Gynecare (salary for research registrar for two years and travel expenses to present work); involved in development of surgical implants for use in surgery for urinary incontinence and pelvic organ prolapse funded by GyneIdeas (salary for research nurse for two years).
Julia Hussein
Julia Hussein is currently employed as Senior Clinical Research Fellow at the University of Aberdeen in Scotland. Her post is funded through the University. She currently receives research grants from several development organisations including the MacArthur Foundation and United Nations agencies. Dr Hussein may also be called upon by various organisations involved in maternal health activities to write papers and make presentations, for which she will be reimbursed expenses, paid an honorarium or treated to meals.
In addition to her academic position, Dr Hussein is also Scientific Director of an evaluation service organisation called Ipact (www.Ipact-int.com). Ipact provides technical assistance to governments and organisations working in developing countries and at global level to improve measurement, monitoring and evaluation of maternal health initiatives. Ipact surpluses are channelled back into the parent research group, Immpact (www.immpact-international.org), to enable further research into measurement of maternal mortality. Ipact is not a legal entity in itself and is wholly administered through the University of Aberdeen. As Scientific Director, Dr Hussein is responsible for writing, contributing and submitting competitive tenders for evaluation studies. She also personally conduct studies and provides advice to organisations contracting Ipact for services either as part of a team or as an individual consultant. Dr Hussein does not receive any personal financial gain from this work.
In her capacity as a researcher in a broad range of developing country, maternal health issues, Dr Hussein also has potential intellectual and academic interests in this area of research. The views and opinions she expresses are solely her own and do not reflect the interests of any of the funding organisations.
Khalid Khan
During the last five years Khalid Khan has received funding to support speaking at meetings from pharmaceuticals (e.g. Ferring Pharmaceuticals) and from various Universities and Societies. Prof khan's research is largely funded by public bodies in the UK and European Union.
Mike Marsh
Over the last year Mike Marsh has been a member of the Lambeth, Southwark and Lewisham Joint Formulary Committee, a member/ chair of the CEMACH mental health in pregnancy review panel and a member of the King's College Hospital Assisted Conception Ethics Committee, for which he receives no fee. He receives remuneration as an Associate and reviewer for the Healthcare Commission, as an undergraduate and postgraduate examiner within the University of London, and from book sales. He is part of a research group that received a Pathfinder grant from the MRC of £160,000 for a study exploring the gestational cortisol axis in depressed and healthy pregnant women.
Pierre Martin-Hirsch
In the last three years, he has attended meetings organised by GSK and Sanofi Pasteur. I have no other competing interests.
Jenny Myers
Jenny Myers has acted as an advisor to Pronota to inform their pre-eclampsia biomarker studies. Her research has been partially funded by Tommy’s Baby Charity.
Raj Naik
Raj Naik has acted as an advisory board member for Sanofi Pasteur MSD.
Anthony Odibo
Anthony Odibo is a principal investigator for several studies funded by the NIH, and pharmaceuticals. He serves as an expert witness on irregular basis in medico-legal cases. Anthony Odibo also receives honorarium for giving lectures and Grand rounds at different academic institutions and for courses at the annual meeting of the Society for Maternal Fetal Medicine.
Aris T Papageorghiou
During the last three years Aris T Papageorghiou has spoken in meetings which were financially supported by Philips and Siemens. He has received funding as invited faculty by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) for attending the 16th World Congress, and has been invited for dinner by ISUOG and GE. He has not received honoraria from these organisations.
Federico Prefumo
During the last three years Federico Prefumo has received funding to defray the expenses of attendance at meetings from the Italian Society for Ultrasound in Obstetrics and Gynaecology, the Turkish Gynecology and Obstetrics Association, the Italian Association of Hospital Obstetricians and Gynaecologists, the Dutch Society of Obstetrics and Gynaecology, the Burlo Garofolo Scientific Institute in Trieste, the University of Naples. He has spoken in meetings which were financially supported by Philips and Bayer Schering.
Dimitrios Siassakos
Limbs&Things have taken Dimitrios Siassakos to dinner and have agreed to sponsor lunch for the course he organises once per year (SMASH: Saving Mothers with Advanced Simulation of High-risk situations). He has no other disclosure to make at present.
Philip Steer
During the last three years Philip Steer has received funding and honoraria to support speaking at meetings from Ferring Pharmaceuticals, Alliance Medical, Pfizer, Milupa, and the Obstetric Anaesthetist’s Association. He has received funding to defray the expenses of attendance at meetings from FIGO (speakers honorarium), Bristol Hospitals Healthcare Trust, the Icelandic Medical Association, and Capetown and Rome Universities, and for research/examining from the Universities of Copenhagen and Lund. He has been treated to dinner while attending a meeting with representatives of Hewlett Packard Ltd. to discuss fetal monitoring. He has received fees for medicolegal opinions from the Welsh Health Legal Authority, Northwick Park Hospitals NHS Trust, Her Majesty’s Police and various solicitors.
Doug Tincello
Non-financial disclosures:
1. Member of Scientific Committee of International Continence Society
2. Member of Scientific Committee of International Urogynaecology Association
3. Chairman of the research subcommittee of British Society of Urogynaecology
4. Member of the Wellbeing of Women Research Advisory Committee
Dr Tincello is principal investigator on the following trial funded by the Moulton Charitable Trust and Wellbeing of Women; the drugs were provided by Allergan:
1. Randomised trial of botulinum toxin A versus placebo for refractory detrusor overactivity (RELAX) .EUDRaCT number: 2004-002981-39; ISRCTN number: ISRCTN26091555.
Financial disclosures:
Dr Tincello has received consultancy payments for work as investigator/advisory board member to trails funded by Ethicon, Pfizer, Eli Lilly & Co. He has also received grants in aid for specific projects from Astellas, ucb Pharma and Ethicon. Financial arrangements have been managed by the University of Leicester Research and Business Office and are used to support Dr Tincello’s research programme.
Austin Ugwumadu
Austin Ugwumadu has received honoraria for speaking at meetings from SMA Nutrition, British Maternal and Fetal Medicine Society, conducting study days on intrapartum care and fetal monitoring in various hospital trusts, and for examining Doctorate and Masters Theses from the Universities of London, Brighton and Kwazulu Natal, Durban South Africa. He has also received funding to offset the expenses of attendance at meetings from the WHO, FIGO, European Association of Perinatal Medicine, Gulf Congress of Obstetrics & Gynaecology, and European Society for Infectious Diseases in Obstetrics & gynaecology. He has received fees for medicolegal opinions from NHS Hospital Trusts and various solicitors.
John Thorp
John Thorp has received consulting fees and honoraria from Adeza Biomedical, PPD Pharmaceuticals,and Glaxo Smith Kline.
Michael Varner
Over the previous three years Michael Varner has received funding and honoraria to participate in National Institutes of Health (US) research grant reviews and symposia. He has also received funding and honoraria to participate in scientific and educational meetings sponsored by the American College of Obstetricians and Gynecologists as well as several US medical schools.
Guest Editor: International Reviews Supplement 2009
Andrew Weeks
As an academic and clinical obstetrician, Andrew Weeks has multiple interests all of which influence his work and decision making. His commercial and organisational connections are listed below, although he recognises that probably the most important influences on his work are colleagues, family and life experiences.
Financial: Andrew Weeks has received research grants from WHO, WellBeing of Women, Rockefeller Foundation, the Bill and Melinda Gates Foundation, Pakistan Higher Education Authority, NHS Strategic Health Authority, Liverpool Women’s NHS Foundation Trust, Gynuity Health Projects and Liverpool Primary Care Trust. Funding for travel has come from the Bill and Melinda Gates Foundation, POPPHI, Alliance Pharmaceuticals, the Federation of International Abortion Providers, the European Society of Contraception, Gynuity Health Projects and the Rockefeller Foundation. Payments for writing have come from Elsevier, Wiley, Churchill Livingstone, RCOG, The Lancet, BMJ and the Metropolitan Police Force. His salary has been paid by the University of Liverpool alone since 2003. Previous salaries have come primarily from the NHS, although he has also received support from the University of Leeds and private clinical work.
Patents: Andrew Weeks is the inventor of the Weeks StationMaster. The patent is held by his employer (the University of Liverpool), although he receives a royalty payment for any sales.
Commercial organisations: Andrew Weeks has an ongoing relationship with Clinical Innovations (Europe) who contributed money to the development of the Weeks StationMaster. Limbs and Things Ltd have also assisted with loans of equipment for clinical studies of the StationMaster. Andrew Weeks also has an informal relationship with Alliance Pharmaceuticals who provided the study medication for the Release Study (of which he was the Chief Investigator) and who are developing a formulation of misoprostol for labour induction. In 2004–5 Andrew Weeks worked as a site investigator for one of their commercial clinical trials. He received no personal payments for this, but did attend a fully funded investigators meeting in Cairo. In the 1990s he ran a research trial for the University of Leeds and his salary was funded by Lederle Pharmaceuticals.
Other organisations: Andrew Weeks is a trustee of three charities - the Ashram Community Trust, the Good Samaritan Trust and the Liverpool-Mulago Partnership for Women’s and Children’s Health. He was a scientific editor of BJOG from 2004–9, the obstetric advisor to the British National Formulary since 2008, an external examiner for Keele University since 2007, and a contributor and referee for the Cochrane Collaboration. He works with the Body Trust who fund a UK registrar to spend time working in Uganda, and run an independent, unfunded website (www.misoprostol.org) to publicise correct dosages of misoprostol for reproductive health.
Awaiting disclosure
Justin Clark
Khalid Khan
